Law360 (January 29, 2007, 12:00 AM EST) -- The Thai government said Monday that is has approved the compulsory licensing of two drugs, one for treating heart disease and one for HIV/AIDS, paving the way for the sale of generic versions of the drugs in that country and effectively breaking their patents.
Thailand’s public health minister, Mongkol Na Songkhla, told reporters that laws were signed Friday that allow for the production of generic versions of Plavix, a blood pressure medication made by Bristol-Myers Squibb Co. and Sanofi-Aventis, and Kaletra, Abbott Laboratories’ “second-line” treatment for...
Thailand Breaks Patents For Plavix, HIV/AIDS Drug
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
